ACS CAN Calls on Administration to Withdraw Rule that Jeopardizes Future of Cancer Research
WASHINGTON, D.C. – Today, the American Cancer Society and the American Cancer Society Cancer Action Network submitted a comment letter to the Office of Management and Budget strongly opposing a proposed rule that would change the federal government’s grantmaking framework. The proposed rule could reshape how billions of dollars in research, education, and public health funding are awarded and comes on the heels of significant disruptions to federal research funding over the past year.
The letter states in part:
“ACS CAN advocates to ensure that the best scientific research that will advance health outcomes is funded and translated into interventions that are accessible by all. That means a process that is transparent, grounded in science, and merit based. Several aspects of this draft rule stand in the way of those ideals, creating an opaque and non-merit-based review process, setting unclear standards that discourage research and interventions critical to improving health outcomes, and generating an environment of uncertainty. Taken together, this rule will impede the federal research enterprise, stifle innovation, limit access to proven health interventions, and would risk not only American’s health but also accelerate the ongoing loss of American leadership in biomedical research as talent and capital move to countries with more predictable research environments.”
The full letter can be found here.